Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from mother to infant during pregnancy, childbirth, blood transfusions, and through shared needles. People are sexually active at a younger age and involve in multiple partners relationship because of which STDs have become more common in recent years. In addition, people can pass STDs to their sexual partners without any symptoms to themselves.
TechNavio's analysts forecast the Global Sexually Transmitted Disease Testing market to grow at a CAGR of 5.64 percent over the period 2013-2018.
Covered in this Report
The Global Sexually Transmitted Disease Testing market can be segmented based on the revenue generated from various applications such as chlamydia testing, gonorrhea testing, syphilis testing, HIV testing, HSV testing, HPV testing, and chancroid testing.
TechNavio's report, Global Sexually Transmitted Disease Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the APAC and EMEA regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Alere
• Becton Dickinson and Company
• bioMérieux
• F. Hoffmann-La Roche
Other Prominent Vendors
• Abbott
• Bio-Rad
• Cepheid
• DiaSorin
• Erba Diagnostics
• Grifols
• Hologic Gen-Probe
• Hospitex Diagnostics
• Siemens Healthcare
• Qiagen
Market Driver
• Growing Incidence of STDs in Adolescents and Young Adults
• For a full, detailed list, view our report
Market Challenge
• Accurate Diagnostics Testing
• For a full, detailed list, view our report
Market Trend
• Ready-to-use Reagents
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Market Landscape
05.1 Market Overview
05.2 Market Size and Forecast
06. Introduction
06.1 Five Forces Analysis
07. Market Segmentation by Application
07.1 Global Chlamydia Testing Market
07.1.1 Market Size and Forecast
07.2 Global Gonorrhea Testing Market
07.2.1 Market Size and Forecast
07.3 Global Syphilis Testing Market
07.3.1 Market Size and Forecast
07.4 Global HIV Testing Market
07.4.1 Market Size and Forecast
07.5 Global HSV Testing Market
07.5.1 Market Size and Forecast
07.6 Global HPV Testing Market
07.6.1 Market Size and Forecast
07.7 Global Chancroid Testing Market
07.7.1 Market Size and Forecast
08. Market Segmentation by End-users
08.1 Global STD Laboratory Testing Market
08.1.1 Market Size and Forecast
08.2 Global STD Point-of-Care Testing Market
08.2.1 Market Size and Forecast
09. Geographical Segmentation
09.1 STD Testing Market in the Americas
09.1.1 Market Size and Forecast
09.2 STD Testing Market in the EMEA Region
09.2.1 Market Size and Forecast
09.3 STD Testing Market in the APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Alere
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2013
18.1.4 Business Segmentation by Revenue 2012 and 2013
18.1.5 Geographical Segmentation by Revenue 2013
18.1.6 Business Strategy
18.1.7 Recent Developments
18.1.8 SWOT Analysis
18.2 Becton, Dickinson and Co.
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Business Segmentation
18.2.4 Revenue Segmentation by Business
18.2.5 Segmental Revenue Comparison - 2013 and 2012
18.2.6 Revenue Segmentation by Geography
18.2.7 Business Strategy
18.2.8 Key Developments
18.2.9 SWOT Analysis
18.2.10 SWOT Overview
18.3 bioMeriux
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Geographical Segmentation by Revenue 2013
18.3.5 Business Strategy
18.3.6 Recent Developments
18.3.7 SWOT Analysis
18.4 Roche Diagnostics
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Geographical Segmentation by Revenue 2013
18.4.5 Business Strategy
18.4.6 Recent Developments
18.4.7 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Segmentation of Global STD Testing Market
Exhibit 2: Market Research Methodology
Exhibit 3: Global STD Testing Market 2013-2018 (US$ billion)
Exhibit 4: Global STD Testing Market Segmentation by Application
Exhibit 5: The Application and Limitations of Diagnostic Tests in Different Stages of Syphilis
Exhibit 6: Socioeconomic Factors Affecting HIV Risks
Exhibit 7: Types of HPV testing
Exhibit 8: Clinical Manifestations Associated with HPV
Exhibit 9: Diagnostics Tests for Chancroid
Exhibit 10: Global STD Testing Market Segmentation by Application 2013
Exhibit 11: Global Chlamydia Testing Market 2013-2018 (US$ billion)
Exhibit 12: Global Gonorrhea Testing Market 2013-2018 (US$ billion)
Exhibit 13: Global Syphilis Testing Market 2013-2018 (US$ billion)
Exhibit 14: Estimated Number of Adverse Outcomes Associated With Syphilis In Pregnancy in Worst, Middle, and Best Case Scenarios of Testing and Treatment Coverage In 2008
Exhibit 15: Global HIV Testing Market 2013-2018 (US$ billion)
Exhibit 16: amfAR Regional Estimation of HIV/AIDS
Exhibit 17: Global HSV Testing Market 2013-2018 (US$ billion)
Exhibit 18: Global HPV Testing Market 2013-2018 (US$ billion)
Exhibit 19: Global Chancroid Testing Market 2013-2018 (US$ billion)
Exhibit 20: Global STD Testing Market Segmentation by Application 2013-2018
Exhibit 21: Global STD Testing Market Segmentation by Application 2013-2018 (US$ billion)
Exhibit 22: Global STD Testing Market Segmentation by End-user
Exhibit 23: Global STD Testing Market Segmentation by End-user 2013
Exhibit 24: Global STD Laboratory Testing Market 2013-2018 (US$ billion)
Exhibit 25: Global STD Point-of-Care Testing Market 2013-2018 (US$ billion)
Exhibit 26: Global STD Testing Market Segmentation by End-users 2013-2018
Exhibit 27: Global STD Testing Market Segmentation by End-users 2013-2018 (US$ billion)
Exhibit 28: Global STD Testing Market by Geographical Segmentation 2013
Exhibit 29: STD Testing Market in the Americas 2013-2018 (US$ billion)
Exhibit 30: STD Testing Market in the EMEA Region 2013-2018 (US$ billion)
Exhibit 31: STD Testing Market in the APAC Region 2013-2018 (US$ billion)
Exhibit 32: Global STD Testing Market by Geographical Segmentation 2013-2018
Exhibit 33: Global STD Testing Market by Geographical Segmentation 2013-2018 (US$ billion)
Exhibit 34: Chlamydia and Gonorrhea rates (per 100,000) Ages 15-19, By Gender, 2011
Exhibit 35: Alere: Business Segmentation by Revenue 2013
Exhibit 36: Alere: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 37: Alere: Geographical Segmentation by Revenue 2013
Exhibit 38: Product Categorization of Becton, Dickinson and Co.
Exhibit 39: Revenue Segmentation of Becton, Dickinson and Co. 2013
Exhibit 40: Revenue Comparison (US$ million)
Exhibit 41: Revenue Segmentation of Becton, Dickinson and Co. by Geography 2013
Exhibit 42: bioMeriux: Business Segmentation by Revenue 2013
Exhibit 43: bioMeriux: Geographical Segmentation by Revenue 2013
Exhibit 44: Roche Diagnostics: Business Segmentation by Revenue 2013
Exhibit 45: Roche Diagnostics: Geographical Segmentation by Revenue 2013
